Skip to main content
. 2024 Aug 30;20(10):7174–7192. doi: 10.1002/alz.14208

TABLE 1.

Tissue sample sources by contributing institutions and cohorts.

Data contributor group Participating cohorts N
Columbia Columbia ADRC 61
Biggs Institute Brain Bank 6
Estudia Familiar de Influencia Genetica en Alzheimer (EFIGA) 4
National Institute on Aging Alzheimer's disease Family Based Study (FBS) 3
Washington Heights, Inwood Columbia Aging Project (WHICAP) 31
Emory Emory Goizueta ADRC 112
Mt Sinai Brain Bank 22
UPenn CNDR 22
Mayo Clinic Mayo Clinic Brain Bank 268
Banner Sun Health Research Institute 43
University of Florida (UFL) 20
Mt. Sinai Mt. Sinai Brain Bank 88
Rush Clinical Core (CLINCOR) 67
Latino Core Study (LATC) 1
Minority Aging Research Study (MARS) 32
Religious Orders Study (ROS) 56
Memory and Aging Project (MAP) 72
Additional samples sourced from AMP‐AD 1.0 to balance proteomics batches a
Mt. Sinai Mt. Sinai Brain Bank 114
Rush ROS 145
MAP 48

Abbreviation: AD, Alzheimer's disease; ADRC, Alzheimer's Disease Research Center; AMP‐AD, Accelerating Medicines Partnership in Alzheimer's Disease; UPenn CNDR, University of Pennsylvania Center for Neurodegenerative Disease Research; WGS, whole genome sequencing.

a

These individuals were sourced from AMP‐AD 1.0 tissue repositories and added to the Diverse cohort samples for proteomics processing only, to fully balance batches by race, ethnicity, age, sex, diagnosis (AD), and tissue region. All individuals have accompanying WGS data generated during the AMP‐AD 1.0 initiative; WGS biospecimen data for these individuals can be found in the AD Knowledge Portal (syn53352733).